A team of clinical researchers based at Johns Hopkins Hospital, Baltimore, Maryland, has reported findings of equivalent efficacy and similar safety and immunogenicity profiles with… Read More »A phase 3 study for a biosimilar of ranibizumab for neovascular AMD has reported equivalent efficacy and similar safety for 705 nAMD patients.
Clinical researchers at the NHS Foundation Trust, Sheffield, UK have found that real-world evidence on the effectiveness and safety of a fluocinolone acetonide (FAc) implant… Read More »Real-world data on fluocinolone acetonide implant treatment with recurrent diabetic macular oedema (DMO) supports fewerclinical visits over 3 years.
Researchers based at the University of Tübingen, Germany have published a clinical study on retinitis pigmentosa (RP) showing that detailed clinical and genetic findings may… Read More »Clinical research on genotype-phenotype correlations in retinitis pigmentosa (RP) are in preparation for gene therapy studies.
Researchers based at the University Hospital of the Ludwig-Maximilians-University, Munich, have reported that the idebenone treatment for LHON indicates a better long-term prognosis than expected… Read More »Clinical research studies for ibdeomne treatment showed a real-world setting for Leber hereditary optic neuropathy (LHON)
Researchers based in Germany and California have reported an innovative procedure for a “Port Delivery System” with ranibizumab (PDS), using a drug delivery system for… Read More »Virtual reality tools for surgical training have been adapted from the aeronautic engineering field
Clinical researchers based at the UCL Institute of Ophthalmology, University College London and Moorfields Eye Hospital, have published a new study that identifies how mobility… Read More »Clinical research on a new mobility assessment tool for RPE65-associated retinal dystrophy.
Clinical researchers at the Jaeb Center for Health Research, Tampa, Florida and the Beetham Eye Institute, Harvard in Boston, (supported by the DRCR Retina Network)… Read More »Five year outcome data is reported for 3 anti-VEGF treatments in diabetic macular edema
Clinical researchers at the Department of Ophthalmology, St. Joseph’s Hospital, London, Ontario have reported that a systematic review and meta-analysis between pars plana vitrectomy to… Read More »A systematic review and meta-analysis has reported outcomes for ocriplasmin treatment and surgery (PPV) for macular hole closure.
International clinical researchers led by the University of Bonn, Germany, have published results of a significant anti-VEGF systematic review and meta-analysis impacting nAMD patient outcomes… Read More »A systematic review and meta-analysis has reported on the impact of anti-VEGF neovascular AMD treatments on patient outcomes and healthcare systems.
A new study from the University of Alberta has been reported to be among the largest study to evaluate the entire Goldmann visual field area… Read More »Largest study of visual field (VF) progression for RP aims to reporting three Goldmann targets (V4e, III4e and I4e)